← Open Payments lookup

JOSHUA NIEKRANZ: Open Payments

NPI 1396407227 · RESTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,790 in 111 payments from 19 companies in 2025. Trend: 2023 $2,169 · 2024 $3,156 · 2025 $2,790

Food & beverage: $2,790
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$345
Alkermes, Inc.10$317
Lundbeck LLC11$261
Otsuka America Pharmaceutical, Inc.11$254
Janssen Pharmaceuticals, Inc5$231
Takeda Pharmaceuticals U.S.A., Inc.12$195
Vanda Pharmaceuticals Inc.5$169
Neurocrine BioSciences, Inc.6$149
Axsome Therapeutics, Inc.7$137
Supernus Pharmaceuticals, Inc.5$125

Products named: REXULTI, CAPLYTA, SPRAVATO, TRINTELLIX, ARISTADA, INGREZZA, Qelbree, LYBALVI.

Industry payments across VA — which companies pay providers there.